Aberg

 "AACTG A5197: A Phase II Double-Blind, Randomized, Placebo-Controlled Study to

 A

 Aberg

 "ACTG A5175: A Phase IV, Prospective, Randomized, Open-Label Evaluation of the Efficacy of Once-Daily Protease Inhibitor and Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Therapy Combinations for Initial Treatment of HIV-1 Infected Individuals from Resource-Limited Settings (PEARLS) Trial"

 A

 Aberg

 "ACTG A5229: A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy"

 A

 Aberg

 ACTG A5001: ACTG Longitudinal Linked Randomized Trials (ALLRT) Protocol

 A

 Aberg

 ACTG A5164: A Phase IV Study of Antiretroviral Therapy for HIV-Infected Adults Presenting with Acute Opportunistic Infections: Immediate Versus Delayed Initiation

 A

 Aberg

 ACTG A5202: A Phase IIIB Randomized Trial of Open-Label Efavirenz or Atazanavir with Ritonavir in Combination with Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects

 A

 Aberg

 ACTG A5206: A Pilot Study to Determine the Impact on Dyslipidemia of the Addition of Tenofovir to Stable Background Antiretroviral Therapy in HIV-Infected Subjects

 A

 Aberg

 ACTG A5211: Phase II, Randomized, Double-Blind Study of the Safety and Efficacy of SCH 417690 (an Orally Administered HIV-1 Entry Inhibitor) in HIV-Infected, Treatment-Experienced Subjects

 A

 Aberg

 ACTG A5212: A Double-Blind Phase II Study of Multiple Doses of Palifermin (rHuKGF) for the Treatment of Inadequate CD4+ Lymphocyte Recovery in Subjects on Potent Antiretroviral Therapy with Plasma HIV-1 RNA Levels

 A

 Aberg

 ACTG A5220: Improving Immune Response to Hepatitis B Vaccine in HIV-Positive Subjects Using Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) as a Vaccine Adjuvant: A Phase II Open-Label Pilot Study\

 A

 Aberg

 ACTG A5221: A Strategy of Immediate Versus Deferred Initiation of Antiretroviral Therapy for HIV-Infected Persons Treated for Tuberculosis with CD4 <200 Cells/mm3

 A

 Aberg

 ACTG A5223: Sex Differences in Lopinavir/Ritonavir Pharmacokinetics among HIV-1-Infected Men and Women

 A

 Aberg

 ACTG A5235: Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment

 A

 Aberg

 ACTG A5240: A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females

 A

 Aberg

 ACTG A5241: The Optimized Treatment that Includes or Omits NRTIs (OPTIONS) Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen

 A

 Aberg

 ACTG A5244: A Double-Blind, Randomized, Pilot Study to Measure the Effect of Treatment Intensification with a Potent Integrase Inhibitor, Raltegravir (MK-0518), on the Level of Persistent Plasma Viremia below 50 copies/mL in Subjects on Protease Inhibitor- or Non-Nucleoside Reverse Transcriptase Inhibitor-Containing Regimens

 A

 Abramson

 Leukocyte Gene Expression in Osteoarthritis

 A

 Achkar

 Immunodiagnostic Tests for the Rapid Diagnosis of TB

 A

 Ayappa

 Automated (AI) Analysis of Sleep Disordered Breathing

 A

 Ayappa

 Relating Sleep Disordered Breathing to Daytime Function

 A

 Ayappa

 Validation of Apnea Risk Evaluation Sleep Scoring

 A

 Banikazemi

 "A Phase 2, Open-Label, Multicenter Study Evaluating the Efficacy, Safety and Pharmacokinetics of Genz-112638 in Gaucher Type 1 Patients"

 D

 Becker

 Determination of the Effect of Radio-Opaque Contrast Media (CM) on Renal Function by Glomerular Filtration Rate (GFR)

 A

 Becker

 Gadolinium Nephrotoxicity: A Measurement of Glomerular Filtration Rate (GFR)

 A

 Belmont

 Lipitor to Prevent Avascular Necrosis in Systemic Lupus Erythematosus

 A

 Bhardwaj

 NYU 03-03: A Randomized, Controlled Trial of Melanoma Treatment: Comparison of Dendritic Cells Versus QS-21 as Adjuvants to Stimulate Anti-tumor Immunity, and Baseline Immune Monitoring of Melanoma Patients

 A

 Bini

 Antiretroviral Therapy and the Hepatitis C Virus

 A

 Blank

 GOG-0199: Prospective Study of Risk-Reducing Salpingo-oophorectomy and Longitudinal

 A

 Blank

 GOG-0209: Randomized Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel and G-CSF Versus Carboplatin/Paclitaxel in Patients with Stage III and IV or Recurrent Endometrial Cancer

 A

 Blank

 GOG-0210: A Molecular Staging Study of Endometrial Carcinoma

 A

 Blank

 NYU 02-30: A Phase I/II Study of OSI 774 in Combination with Carboplatin and Paclitaxel in Patients with Ovarian or

 A

 Blank

 NYU 03-17: A Phase II Study of Oxaliplatin in Combination with Paclitaxel in Patients with Locally Recurrent or Metastatic Cervical Cancer

 A

 Borkowsky

 "PENPACT 1 (PENTA 9/PACTG 390): A

 A

 Borkowsky

 A 48-Week, Phase II, Non-Comparative, Open-Label, Multi-Cohort, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GW433908/Ritonavir BID when Administered to HIV-1 Infected, PI-Naive and Experienced Pediatric Subjects, 2 to 18 Years Old and of GW433908 BID Administered to PI-Naive, Pediatric Subjects 2 to <6 Years Old

 D

 Borkowsky

 IMPAACT P1065: Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal conjugate Vaccine in HIV-Infected Youth

 A

 Borkowsky

 PACTG 1020-A: Phase I/II Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and -Experienced HIV-Infected Infants, Children and Adolescents

 A

 Borkowsky

 PACTG 1025: Perinatal Core Protocol

 A

 Borkowsky

 PACTG P1055: Psychiatric Co-Morbidity in Perinatally HIV-Infected Children and Adolescents

 A

 Borkowsky

 PACTG P1058: Intensive Pharmacokinetic Studies of Antiretroviral Drug Combinations in Children

 A

 Borkowsky

 PH 100: Surveillance Monitoring for ART Toxicities Study in HIV-Uninfected Children Born to HIV-Infected Women (SMARTT Study)

 A

 Bosland

 Prostate Cancer Chemoprevention Clinical Trials

 A

 Buyon

 Predictors of Pregnancy Outcomes in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

 A

 Buyon

 Preventive IVIG Therapy for Congenital Heart Block (PITCH)

 A

 Buyon

 The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) Study

 D

 Chinitz

 Adenovirus as a Possible Etiology of Atrial Fibrillation

 A

 Clancy

 "Circulating Endothelial Cells, a Biomarker to Predict Subclinical Atherosclerosis in Patients with SLE"

 A

 Clelland

 Alzheimer's Diagnosis: Leukocyte Multigene Syndrome

 A

 Clelland

 Biopterin Deficit in Schizophrenia: Genetic Dissection of BH4 Biosynthesis

 A

 Clelland

 Schizophrenia Diagnosis: Leukocyte Multigene Signatures

 A

 Coffey

 Open Label Trial of Aripiprazole in Children and Adolescents with Tourette's Disorder

 A

 Condos

 Aerosol Deposition and Cellular Response in Patients Receiving Aerosol Interferon-gamma for Idiopathic Pulmonary Fibrosis (IPF)

 A

 Condos

 Prospective Evaluation Of Patients With Idiopathic Pulmonary Fibrosis Through An IPF Registry

 A

 Condos

 Tuberculosis Research Blood Bank

 A

 Convit

 "Type 2 Diabetes in Adolescence, Cognition, and the Brain"

 A

 Convit

 Brain in Diabetes: Response to Increased Metabolic Demand

 A

 Di Rocco

 Treatment of Depression in Parkinson's Disease

 A

 Feit

 Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D)

 A

 Formenti

 "Response, Resistance and Metastasis of Locally-Advanced Breast Cancer (LABC) in a Multi-Ethnic Cohort"

 A

 Formenti

 NYU 01-16: Locally Advanced Breast Cancer: Individualized Treatment Based on Tumor Molecular Characteristics

 A

 Francois

 The Role of Bacterial Colonization in the Development of Upper Gastrointestinal Pathology

 A

 Francois

 The Role of Inflammatory Polymorphisms in Colorectal Neoplasia

 A

 Friedberg

 Longitudinal Study of Ocular Complications of AIDS

 A

 Gabbay

 Immune System Activation in Adolescent Suicide

 A

 Gabbay

 Omega-3 Fatty Acids in Adolescents with Depression

 A

 Grant

 Effect of Temporal Lobectomy on Sensory Deficits in Temporal Lobe Epilepsy (TLE)

 A

 Hochster

 A Phase 2 Study of Temozolomide (SCH 52365) in Subjects with Advanced Aerodigestive Tract Cancers Selected for Methylation of O6-Methyl-guanine-DNA Methyltransferase (MGMT) Promoter

 D

 Hochster

 A Phase II Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer

 D

 Hochster

 ECOG E5202: A Randomized Phase III Study Comparing 5-FU, Leucovorin and oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers

 A

 Hochster

 ECOG E5204: Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Pre-Operative Chemoradiation

 A

 Hochster

 ECOG N0147: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer

 A

 Hochster

 NYU 04-10: A Phase II Study of Cetuximab Plus Biweekly Capecitabine and Oxaliplatin (C-CO2) in the Treatment of Patients with EGFR-Expressing Metastatic Colorectal Cancer

 A

 Kleinberg

 "A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess Efficacy and Safety of LB03002 Administered Weekly in Adults with Growth Hormone Deficiency [BRANY]"

 D

 Kleinberg

 "Extension to a Multicenter, Randomized, Crossover, Open-Label, Dose-Finding Study to Compare the Safety, Efficacy and PK/PD Relationship of Multiple Doses of SOM230 (200 mcg, 44 mcg and 600 mcg bid) and Doses of Open-Label Sandostatin (100 mcg tid) in Acromegalic Patients"

 D

 Kleinberg

 A Multi-Center, Open Label Study to Assess the Ability of Subjects with Acromegaly, or Their Partners, to Administer Somatuline Autogel

 D

 Kleinberg

 A Phase III, Open-Label, Uncontrolled, Multicenter, Rollover Study to Assess Safety and Efficacy of LB03002 Administered Weekly in Adults with Growth Hormone Deficiency [BRANY]

 D

 Kleinberg

 Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

 A

 Kleinberg

 Does Surgical Debulking of Pituitary Adenomas Improve Responsiveness to Octreotide LAR in the Treatment of Acromegaly: An Investigator-Initiated Study

 A

 Krieger

 Mechanisms of Endothelial Dysfunction in Sleep Apnea

 A

 Muggia

 NYU 00-60: Cancer Screening and Prevention Project for High Risk Women

 A

 Novik

 ECOG PACCT-1: Trial Assigning Individualized Options for Treatment (The TAILORx Trial)\

 A

 Oliver

 Altered Dendritic Cell Function in

 A

 Oliver

 T Cell Immunity in Collagen Biosynthesis of Scleroderma

 A

 Ost

 Interventional Bronchoscopy Registry for Assessment of Long-Term Outcomes and Impact on Quality of Life

 A

 Pena-Sing

 FREEDOM Trial: Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease

 A

 Pillon

 Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)

 D

 Pollack

 "Assessment of the Safety, Efficacy, Tolerability, and Pharmacokinetics of PEG-Intron Plus REBETOL in Pediatric Patients with Chronic Hepatitis C"

 D

 Pollack

 A Phase 2, Randomized, Double-Blind Study Exploring the Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate (DF) Monotherapy Versus Emtricitabine plus Tenofovir DF Fixed-Dose Combination Therapy in Subjects Currently Being Treated with Adefovir Dipivoxil for Chronic Hepatitis B and Having Persistent Viral Replication\

 D

 Pollack

 A Phase 3 Double Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents (Age 2 to <18) with Chronic Hepatitis B [BRANY]

 D

 Pomara

 A Multicenter, Randomized, 24-52 Week, double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Saredutant 100 mg Once Daily in the Prevention of Relapse of Depressive Symptoms in Outpatients with Major Depressive Disorder who Achieved an Initial Response to 12 Weeks of Open-Label Treatment with Saredutant 100 mg Once Daily\

 D

 Pomara

 Plasma and CSF Abeta Peptides in Late-Onset Major Depression

 A

 Rapoport

 Auto CPAP Based on Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome

 A

 Rapoport

 Effect of Nasal Resistance on Delivered Continuous Positive Airway Pressure in the Treatment of Obstructive Sleep Apnea

 A

 Rapoport

 Impact of CPAP on Functional Outcomes in Milder OSA

 A

 Reibman

 Bronchoalveolar Lavage and Brushings In Normal Volunteers

 A

 Reibman

 Disease Modifying Genes in Severe Asthma

 A

 Reibman

 NYU World Trade Center Responder

 A

 Reibman

 Study of Acid Reflux Asthma (SARA)

 A

 Reibman

 The Study of Acid Reflux in Children with Asthma

 A

 Reisberg

 Aging and Dementia Longitudinal Course of Subgroups

 A

 Ren

 The Impact of Weight Loss after Bariatric Surgery on Esophageal Function and Sleep

 A

 Reynolds

 Study of Women with Acute Coronary Syndromes and Non-Obstructive CAD (SWAN)

 A

 Reynolds

 Trial to Assess Chelation Therapy (TACT)

 A

 Richardson

 A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Assess the Effect of Quercitin as Monotherapy on Growth Hormone Secretion in Acromegaly

 A

 Rom

 Mechanisms of Asbestos Related Disease

 A

 Rom

 NYU Biomarker Clinical and Epidemiologic Center

 A

 Rosenthal

 Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)

 A

 Ryan

 "NYU 04-72: Neoadjuvant Therapy of Gastric Cancer with Irinotecan, Cisplatin, and Cetuximab Followed by Surgical Resection and Adjuvant Chemoradiation"

 A

 Ryan

 NYU 04-33: A Phase I/II Study of Taxotere, Oxaliplatin and 5-Fluorouracil

 A

 Teperman

 A Phase II, Open-Label, Multi-Center Prospective, Conversion Study in Stable Liver Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-A-Day to Prograf Capsules Twice-A-Day [BRANY]

 D

 Tiersten

 A Phase II Study of Oxaliplatin Combined with Continuous Infusion Topotecan as Chemotherapy for Patients with Previously Treated Ovarian Cancer

 A

 Valentine

 The Development and Effect of HIV Specific CD4 Responses to Early Intervention in Primary HIV Infection Using Antiretroviral Therapy Alone or Antiretroviral Therapy with Vaccination

 A

 Wan

 "A Multicenter, Randomized, Double-Masked, Comparator Study of the Safety and

 A

 Wan

 A Multicenter, Open-Label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150 Micrograms of Nestorone and 15 Micrograms of Ethinyl Estradiol\

 A

 Weiden

 HIV/TB Interaction in the Lung

 A

 Wu

 A Phase-II Trial of ZIO-101 in Advanced Hepatocellular Carcinoma

 D

 de Leon

 Biomarkers in Early Alzheimer's Disease

 A

 de Leon

 Clinical Correlates of Longitudinal PET

 A

 de Leon

 Predictors of Cognitive Decline in Normal Aging

 A